(Total Views: 867)
Posted On: 12/19/2021 3:02:28 PM
Post# of 36541
Docj, thank you very much. I found it in USPTO database, Olaregen bought it from “Activation Therapeutics Inc." (Gene)
I’m also checking Ii-key patent, in USPTO database, the owner is GENEREX PHARMACEUTICALS INC. there are 6 note holders, Do you know what’s the relationship between Generex Biotechnology Corporation and GENEREX PHARMACEUTICALS INC
About Ii-key patent, #7179645 expires Nov 6,2023
2008-04-04 Assignor GENEREX PHARMACEUTICALS INC.
had 6 security assignments to these 6 assignees
IROQUOIS MASTER FUND LTD.
PORTSIDE GROWTH AND OPPORTUNITY FUND
SMITHFIELD FIDUCIARY LLC
CRANSHIRE CAPITAL, L.P.
ROCKMORE INVESTMENT MASTER FUND LTD.
IROQUOIS CAPITAL OPPORTUNITY FUND, LP
I’m also checking Ii-key patent, in USPTO database, the owner is GENEREX PHARMACEUTICALS INC. there are 6 note holders, Do you know what’s the relationship between Generex Biotechnology Corporation and GENEREX PHARMACEUTICALS INC
About Ii-key patent, #7179645 expires Nov 6,2023
2008-04-04 Assignor GENEREX PHARMACEUTICALS INC.
had 6 security assignments to these 6 assignees
IROQUOIS MASTER FUND LTD.
PORTSIDE GROWTH AND OPPORTUNITY FUND
SMITHFIELD FIDUCIARY LLC
CRANSHIRE CAPITAL, L.P.
ROCKMORE INVESTMENT MASTER FUND LTD.
IROQUOIS CAPITAL OPPORTUNITY FUND, LP
(1)
(0)Scroll down for more posts ▼
